neuroendocrine carcinoma
Showing 26 - 50 of 55
Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)
Recruiting
- Neuroendocrine Carcinoma
- FOLFOXIRI Protocol
- Cisplatin injection
-
Caen, France
- +5 more
Apr 13, 2021
Neuroendocrine Carcinoma Trial in Beijing (Nab-paclitaxel Combined With Bevacizumab)
Recruiting
- Neuroendocrine Carcinoma
- Nab-paclitaxel Combined With Bevacizumab
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 9, 2021
Neuroendocrine Tumors, Neuroendocrine Carcinoma, Temozolomide Trial in Seoul (TEMCAP)
Active, not recruiting
- Neuroendocrine Tumors
- +3 more
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Dec 13, 2020
Early Treatment Response in NEN (REBORN)
Recruiting
- Neuroendocrine Tumors
- +4 more
- Somatostatin analog; chemotherapy
-
Rome, ItalyAndrea M Isidori
Dec 2, 2020
is to Demonstrat That Vacuum-assisted Closure Versus
Unknown status
- Melanoma
- +4 more
- PREVENA
-
Nancy, FranceCHRU
Oct 6, 2020
Neuroendocrine Carcinoma Trial in Houston (68Ga-DOTATATE PET scan)
Completed
- Neuroendocrine Carcinoma
- 68Ga-DOTATATE PET scan
-
Houston, TexasRadio- Isotope Therapy of America
Oct 5, 2020
Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)
Terminated
- Neuroendocrine Tumors
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2020
Gastrointestinal Cancer, Neuroendocrine Carcinoma, Skin Cancer Trial in Columbus (Aromatherapy and Essential Oils, Subject
Completed
- Gastrointestinal Cancer
- +2 more
- Aromatherapy and Essential Oils
- Subject Diary
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 31, 2020
Neuroendocrine Carcinoma Trial in Toronto (Avelumab)
Completed
- Neuroendocrine Carcinoma
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Mar 17, 2020
Neuroendocrine Carcinoma Trial in Italy (Everolimus)
Unknown status
- Neuroendocrine Carcinoma
-
Modena, Emilia - Romagna, Italy
- +4 more
Feb 20, 2020
Neuroendocrine Carcinoma Trial in Beijing (irinotecan cisplatin, Etoposide cisplatin)
Terminated
- Neuroendocrine Carcinoma
- irinotecan cisplatin
- Etoposide cisplatin
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 19, 2020
Neuroendocrine Carcinoma Trial in Bergen (Everolimus , temozolomide)
Completed
- Neuroendocrine Carcinoma
- Everolimus , temozolomide
-
Bergen, NorwayHaukeland University Hospital
Dec 18, 2019
Extensive Stage Small Cell Lung Carcinoma, Large Cell Lung Carcinoma, Neuroendocrine Carcinoma Trial in United States
Completed
- Extensive Stage Small Cell Lung Carcinoma
- +4 more
- Cisplatin
- +3 more
-
Loma Linda, California
- +427 more
Jan 17, 2019
Neuroendocrine Carcinoma Trial in Beijing (SOX)
Unknown status
- Neuroendocrine Carcinoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 10, 2017
Neuroendocrine Carcinoma Trial in Beijing (FOLFIRI Protocol)
Unknown status
- Neuroendocrine Carcinoma
- FOLFIRI Protocol
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
May 30, 2017
Neuroendocrine Carcinoma, Breast Cancer, Ovarian Cancer Trial in Copenhagen (Injection of 68Ga-NODAGA-E(c[RGDyK])2)
Unknown status
- Neuroendocrine Carcinoma
- +2 more
- Injection of 68Ga-NODAGA-E(c[RGDyK])2
-
Copenhagen, DenmarkDepartment of Clinical Physiology, Nuclear Medicine and PET, Rig
Nov 18, 2016
Neuroendocrine Carcinoma Trial in Nashville (68Ga-DOTATATE PET scan)
Completed
- Neuroendocrine Carcinoma
- 68Ga-DOTATATE PET scan
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 25, 2016
Neuroendocrine Carcinoma Trial in United States (Bevacizumab, Pertuzumab, Sandostatin LARĀ® Depot)
Neuroendocrine Carcinoma Trial in Tampa (Octreotide LAR)
Terminated
- Neuroendocrine Carcinoma
- Octreotide LAR
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 6, 2015
Neuroendocrine, Neuroendocrine Tumor, Neuroendocrine Cancer Trial in Kenner (68Ga-DOTATATE will be given in tracer doses and
Unknown status
- Neuroendocrine
- +7 more
- 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.
-
Kenner, LouisianaOchsner Medical Center - Kenner
Jan 16, 2014
Neuroendocrine Carcinoma Trial in Houston (Avastin, RAD001)
Completed
- Neuroendocrine Carcinoma
-
Houston, TexasU.T.M.D. Anderson Cancer Center
May 14, 2013
Merkel Cell Carcinoma, Islet Cell Carcinoma, Neuroendocrine Carcinoma Trial in Houston (antineoplaston A10, antineoplaston
Withdrawn
- Merkel Cell Carcinoma
- +3 more
- antineoplaston A10
- +7 more
-
Houston, TexasBurzynski Clinic
Jul 9, 2013
Carcinoma of Unknown Primary, Neuroendocrine Carcinoma, Neuroendocrine Carcinoma of the Skin Trial in New York (irinotecan HCl)
Completed
- Carcinoma of Unknown Primary
- +2 more
- irinotecan hydrochloride
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 18, 2013
Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)
Completed
- Islet Cell Carcinoma
- +3 more
- Everolimus 10 mg
- Octreotide Depot
-
Birmingham, Alabama
- +53 more
May 6, 2013